Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma

被引：22

作者：

Railan, D ^{[1
]}

Fivenson, DP

Wittenberg, G

机构：

[1] Henry Ford Hosp, Detroit, MI 48202 USA

[2] Rapid City Med Ctr, Rapid City, SD USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2000年 / 43卷 / 02期

关键词：

D O I：

10.1067/mjd.2000.106373

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：323 / 324

页数：2

共 5 条

[1] THE SYSTEMIC CAPILLARY LEAK SYNDROME - APPEARANCE OF INTERLEUKIN-2-RECEPTOR-POSITIVE CELLS DURING ATTACKS [J].

CICARDI, M ;

GARDINALI, M ;

BISIANI, G ;

ROSTI, A ;

ALLAVENA, P ;

AGOSTONI, A .

ANNALS OF INTERNAL MEDICINE, 1990, 113 (06) :475-477

[2]

LISSONI P, 1990, International Journal of Biological Markers, V5, P195

[3] Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies [J].

Nichols, J ;

Foss, F ;

Kuzel, TM ;

LeMaistre, CF ;

Platanias, L ;

Ratain, MJ ;

Rook, A ;

Saleh, M ;

Schwartz, G .

EUROPEAN JOURNAL OF CANCER, 1997, 33 :S34-S36

[4] Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome [J].

Orucevic, A ;

Lala, PK .

CANCER AND METASTASIS REVIEWS, 1998, 17 (01) :127-142

[5]

THOMPSON JA, 1994, CANCER RES, V54, P3436

← 1 →